Skip to main content

Table 1 Characteristics of the male patients (Omega-3 FAs, 4w)

From: Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters

 

Pre

Post

n

14

Age (years)

40.2 ± 1.7

Body mass index (kg/m2)

25.9 ± 0.7

26.1 ± 0.7

Waist circumference (cm)

89.5 ± 1.8

89.0 ± 2.0

Biochemical data

  

 Total cholesterol (mg/dl)

217.2 ± 7.1

207.6 ± 8.5

 HDL cholesterol (mg/dl)

57.6 ± 3.7

57.6 ± 4.3

 LDL cholesterol (mg/dl)

132.6 ± 6.5

125.8 ± 8.3

 Triglycerides (mg/dl)

163.7 ± 20.6

98.1 ± 11.4*

 Glucose (mg/dl)

97.6 ± 2.2

98.0 ± 1.8

 Insulin (μU/ml)

7.9 ± 1.9

6.5 ± 1.2

 HOMA-IR

1.99 ± 0.56

1.57 ± 0.28

 HbA1c (%)

5.5 ± 0.1

5.5 ± 0.1

 hsCRP (mg/dl)

0.60 ± 0.17

0.75 ± 0.20

 HMW-adiponectin (μg/ml)

2.42 ± 0.23

2.31 ± 0.23

 FABP4 (ng/ml)

13.5 ± 1.5

11.5 ± 1.1*

  1. Variables are expressed as n or means ± SEM
  2. hsCRP high-sensitivity C-ractive protein, HMW high-molecular weight
  3. *P <0.05 vs. Pre